Despite a tough economic environment in 2024, aesthetics consumers continued to spend – and they’re not planning to stop in 2025. According to research from NewBeauty, the majority of consumers plan to maintain the same level of spending on aesthetics treatments; even if they had to reduce their overall spending, they’re much more likely to cut...
We sat down with Dr. Marc Estes and Dr. Rickin Shah, founders of PURE Regenerative Medicine, to discuss their approach to exosomes in aesthetics and experience with EXO CR.
In the world of aesthetics, delivering exceptional results is only half of the equation. Ensuring that patients have a seamless, comfortable, and effective post-treatment experience is equally crucial. As providers, creating a post-treatment regimen that enhances results and fosters patient satisfaction can set you apart from the competition.
MELVILLE, N.Y., April 30, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced that it has entered into a five-year exclusive supply agreement with Cartessa Aesthetics, LLC (“Cartessa”), a leading North...
2023 was a financially challenging year for many businesses and consumers, due to rising interest rates and widespread inflation. However, time and time again, the aesthetics industry has proven to be resilient in tough economic environments. And while consumers may be cutting back in other aspects of life, they’re continuing to spend in...
Platelet-rich plasma (PRP) and exosomes both offer effective and innovative solutions for tissue repair, facial rejuvenation, and hair restoration.
As the landscape of aesthetic treatments continues to evolve, the latest exciting development has been the use of exosomes.
Microneedling has become a staple in the cosmetic industry, long celebrated for its non-invasive and transformative effects on the skin. As this treatment continues to evolve, the integration of exosomes has emerged as a revolutionary approach, providing numerous benefits for regenerative aesthetics.
In their roundup of the biggest skincare trends of 2024, Allure highlighted exosome products, including Cartessa's Chronos ExoCR, as the buzzy treatment to watch. Below is an excerpt from These Will Be the Biggest Skin-Care Trends of 2024, written by Jessica Ourisman.
In the ever-evolving landscape of regenerative aesthetics, where innovation meets precision, Cartessa Aesthetics is proud to introduce Chronos, the groundbreaking exosome treatment and advanced biologics brand that sets a new industry standard.
Exosome treatments have emerged as a revolutionary development for regenerative medicine, captivating the attention of healthcare professionals and patients alike.
Cartessa's foray into biologics and the exosome category in particular was featured in a recent issue of Aesthetic Insights. Below is an excerpt from New Regenerative Aesthetics Entrant Raises the Bar.
If we learned anything in the last three years, it’s that the demand for aesthetic treatments is pandemic proof. In fact, the aesthetics medicine market grew from 2020 to 2021 and is estimated to continue growing at a CAGR of 13.1% from 2022 to 2030.
